HSIC Henry Schein, Inc. - Common Stock
Tentang Henry Schein, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
Baca selengkapnya
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
HSIC Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
HSIC Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
HSIC Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 7 28,0%
- Beli 7 28,0%
- Tahan 10 40,0%
- Jual 1 4,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
16 analis · 2026-08-19Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $1.27 | $1.26 | 0.01% |
| 31 Maret 2026 | $1.32 | $1.24 | 0.08% |
| 31 Des. 2025 | $1.34 | $1.33 | 0.01% |
| 30 Sep. 2025 | $1.38 | $1.30 | 0.08% |
| 30 Juni 2025 | $1.10 | $1.22 | -0.12% |
| 31 Maret 2025 | $1.15 | $1.13 | 0.02% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 17
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Neraca 26
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Arus Kas 19
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Profitabilitas 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Tingkat Pertumbuhan 9
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | -245,089,515 | 120,199,552 | 121,927,867 | 123,776,073 | -255,840,759 | 126,124,715 | 127,784,380 | 128,720,661 | -269,727 | 130,388,353 | 131,365,789 | -274,191,526 | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | -246,803,540 | 121,036,247 | 122,636,948 | 124,848,221 | -257,691,792 | 127,054,934 | 128,646,506 | 129,769,580 | -401,001 | 131,442,135 | 133,039,886 | -277,434,915 | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Arus Kas 17
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Profitabilitas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Valuasi (TTM) 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.40B | $13.12B | · | $12.92B | $12.72B | $12.65B | · | $12.64B | $12.57B | $12.49B | · | $12.39B | $12.34B | · | $12.45B | |
| Net Income TTM | $388M | $404M | · | $396M | $399M | $406M | · | $433M | $474M | $491M | · | $548M | $612M | · | $653M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 25.9 | 21.6 | · | 20.6 | 23.2 | 21.6 | · | 21.9 | 17.7 | 20.2 | · | 18.1 | 18.3 | · | 14.3 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| P / FCF | · | -67.6 | · | · | · | 1398.1 | · | · | · | 62.2 | · | · | · | · | · | |
| EV / EBITDA | 40.7 | 34.8 | · | 35.3 | 64.2 | 36.8 | · | 61.6 | 53.5 | 44.0 | · | 47.5 | · | · | · | |
| EV / FCF | · | -75.1 | · | · | · | 1521.4 | · | · | · | 62.9 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.8 | · | · | · | |
| Earnings Yield | 3.9% | 4.6% | · | 4.8% | 4.3% | 4.6% | · | 4.6% | 5.7% | 5.0% | · | 5.5% | 5.5% | · | 7.0% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Pendapatan | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Margin Kotor % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Margin Operasi % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Laba Bersih | $398M | $390M | $416M | $538M | $631M |
| EPS Dilusian | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
Neraca
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Rasio Lancar | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Rasio Cepat | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
Arus Kas
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $573M | $700M | $353M | $506M | $631M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 603 pengaju · $7.6B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 68 (-4 vs Kuartal sebelumnya) | 60 (+14 vs Kuartal sebelumnya) | 172 (-5 vs Kuartal sebelumnya) | 203 (+21 vs Kuartal sebelumnya) | +14.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1.307.257.713 | 15.652.032 | 17,12% | Saham |
| Artisan Partners Limited Partnership | $540.162.844 | 6.467.467 | 7,07% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $530.073.795 | 6.346.669 | 6,94% | Saham |
| STATE STREET CORP | $359.576.652 | 4.305.276 | 4,71% | Saham |
| FMR LLC | $349.717.366 | 4.187.229 | 4,58% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345.225.076 | 4.133.442 | 4,52% | Saham |
| AMERICAN CENTURY COMPANIES INC | $288.743.396 | 3.457.175 | 3,78% | Saham |
| Southpoint Capital Advisors LP | $275.616.000 | 3.300.000 | 3,61% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $256.689.867 | 3.073.394 | 3,36% | Saham |
| CITADEL ADVISORS LLC | $243.970.272 | 2.921.100 | 3,20% | Saham |
| Palestra Capital Management LLC | $204.347.632 | 2.446.691 | 2,68% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $200.544.294 | 2.405.837 | 2,63% | Saham |
| FIDUCIARY MANAGEMENT INC /WI/ | $151.785.323 | 1.817.353 | 1,99% | Saham |
| Burgundy Asset Management Ltd. | $151.049.204 | 2.170.871 | 1,98% | Saham |
| LYRICAL ASSET MANAGEMENT LP | $122.553.156 | 1.467.351 | 1,60% | Saham |
| Swedbank AB | $109.479.854 | 1.310.822 | 1,43% | Saham |
| M.D. Sass, LLC | $107.485.396 | 1.286.942 | 1,41% | Saham |
| SNYDER CAPITAL MANAGEMENT L P | $107.341.992 | 1.285.225 | 1,41% | Saham |
| NORGES BANK | $103.383.729 | 1.237.832 | 1,35% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86.592.951 | 1.036.793 | 1,13% | Saham |
| NOMURA HOLDINGS INC | $77.065.658 | 922.721 | 1,01% | Saham |
| PZENA INVESTMENT MANAGEMENT LLC | $71.888.420 | 860.733 | 0,94% | Saham |
| Ananym Capital Management, LP | $57.978.164 | 694.183 | 0,76% | Saham |
| Ulysses Management LLC | $55.570.700 | 665.358 | 0,73% | Saham |
| STALEY CAPITAL ADVISERS INC | $55.252.489 | 661.548 | 0,72% | Saham |
| DME Capital Management, LP | $52.173.274 | 624.680 | 0,68% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $45.489.502 | 544.654 | 0,60% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35.970.895 | 430.686 | 0,47% | Saham |
| GOLDMAN SACHS GROUP INC | $35.392.853 | 423.765 | 0,46% | Saham |
| Clarkston Capital Partners, LLC | $35.168.100 | 421.074 | 0,46% | Saham |
| LONE PEAK GLOBAL INVESTORS LLC | $33.404.158 | 399.954 | 0,44% | Saham |
| GAMCO INVESTORS, INC. ET AL | $30.537.668 | 365.633 | 0,40% | Saham |
| PRIVATE MANAGEMENT GROUP INC | $27.285.483 | 326.694 | 0,36% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $25.194.142 | 301.654 | 0,33% | Saham |
| BlackRock, Inc. | $24.670.305 | 295.382 | 0,32% | Saham |
| GABELLI FUNDS LLC | $24.182.047 | 289.536 | 0,32% | Saham |
| Zuckerman Investment Group, LLC | $24.062.613 | 288.106 | 0,32% | Saham |
| JANE STREET GROUP, LLC | $22.976.352 | 275.100 | 0,30% | Opsi beli |
| Petrus Trust Company, LTA | $22.550.400 | 270.000 | 0,30% | Saham |
| P2 Capital Partners, LLC | $22.089.871 | 264.486 | 0,29% | Saham |
| BANK OF AMERICA CORP /DE/ | $21.414.277 | 256.397 | 0,28% | Saham |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $21.151.189 | 253.247 | 0,28% | Saham |
| RHUMBLINE ADVISERS | $21.008.017 | 251.534 | 0,28% | Saham |
| UBS Group AG | $20.880.000 | 250.000 | 0,27% | Opsi jual |
| LAZARD ASSET MANAGEMENT LLC | $20.493.720 | 245.375 | 0,27% | Saham |
| Cresset Asset Management, LLC | $20.165.236 | 241.442 | 0,26% | Saham |
| Balyasny Asset Management L.P. | $19.401.863 | 232.302 | 0,25% | Saham |
| Quantinno Capital Management LP | $18.131.858 | 217.096 | 0,24% | Saham |
| Vanguard Global Advisers, LLC | $17.149.245 | 205.331 | 0,22% | Saham |
| FIRST TRUST ADVISORS LP | $16.585.245 | 198.579 | 0,22% | Saham |
| EVERETT HARRIS & CO /CA/ | $16.551.743 | 198.177 | 0,22% | Saham |
| California Public Employees Retirement System | $16.351.212 | 195.776 | 0,21% | Saham |
| Swiss National Bank | $16.344.864 | 195.700 | 0,21% | Saham |
| Leith Wheeler Investment Counsel Ltd. | $15.975.960 | 191.283 | 0,21% | Saham |
| WESTWOOD HOLDINGS GROUP INC | $15.708.859 | 188.085 | 0,21% | Saham |
| Woodline Partners LP | $15.637.951 | 187.236 | 0,20% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.874.912 | 178.100 | 0,19% | Opsi beli |
| Amundi | $14.369.366 | 172.047 | 0,19% | Saham |
| Stephens Investment Management Group LLC | $14.100.765 | 168.831 | 0,18% | Saham |
| NUANCE INVESTMENTS, LLC | $14.045.116 | 168.165 | 0,18% | Saham |
| JANE STREET GROUP, LLC | $13.541.515 | 162.135 | 0,18% | Saham |
| BARCLAYS PLC | $12.852.476 | 153.885 | 0,17% | Saham |
| James J. Burns & Company, LLC | $12.843.455 | 153.777 | 0,17% | Saham |
| Ulysses Management LLC | $12.528.000 | 150.000 | 0,16% | Opsi beli |
| Marathon Asset Management Ltd | $11.609.195 | 139.002 | 0,15% | Saham |
| CLARK ESTATES INC/NY | $11.275.200 | 135.000 | 0,15% | Saham |
| PFM Health Sciences, LP | $11.227.009 | 134.423 | 0,15% | Saham |
| Holocene Advisors, LP | $10.191.528 | 122.025 | 0,13% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $10.070.173 | 120.572 | 0,13% | Saham |
| HEARTLAND ADVISORS INC | $10.022.400 | 120.000 | 0,13% | Saham |
| BANK OF NOVA SCOTIA | $9.519.692 | 113.981 | 0,12% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $9.502.822 | 113.779 | 0,12% | Saham |
| HFR Wealth Management, LLC | $9.454.965 | 113.206 | 0,12% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9.138.210 | 123.992 | 0,12% | Saham |
| Illinois Municipal Retirement Fund | $8.914.173 | 106.731 | 0,12% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $8.898.137 | 106.539 | 0,12% | Saham |
| Clearline Capital LP | $8.696.854 | 104.129 | 0,11% | Saham |
| Stenger Family Office, LLC | $8.511.793 | 24.721 | 0,11% | Saham |
| FIRST MANHATTAN CO. LLC. | $8.509.769 | 101.889 | 0,11% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8.184.793 | 97.998 | 0,11% | Saham |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $8.101.440 | 97.000 | 0,11% | Saham |
| Man Group plc | $7.975.325 | 95.490 | 0,10% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $7.705.472 | 92.259 | 0,10% | Saham |
| BANYAN CAPITAL MANAGEMENT, INC. | $7.621.951 | 91.259 | 0,10% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $7.521.178 | 90.052 | 0,10% | Saham |
| NEUBERGER BERMAN GROUP LLC | $6.802.084 | 81.443 | 0,09% | Saham |
| ALLIANCEBERNSTEIN L.P. | $6.719.450 | 91.173 | 0,09% | Saham |
| FRANKLIN RESOURCES INC | $6.613.615 | 79.186 | 0,09% | Saham |
| Berger Financial Group, Inc | $6.535.023 | 78.245 | 0,09% | Saham |
| WINTON GROUP Ltd | $6.439.392 | 77.100 | 0,08% | Saham |
| RIVER GLOBAL INVESTORS LLP | $6.404.253 | 92.547 | 0,08% | Saham |
| Brandywine Global Investment Management, LLC | $6.305.262 | 83.425 | 0,08% | Saham |
| Foyston, Gordon & Payne Inc | $6.304.173 | 75.481 | 0,08% | Saham |
| Allianz Asset Management GmbH | $6.210.714 | 74.362 | 0,08% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.145.736 | 73.584 | 0,08% | Saham |
| AdvisorShares Investments LLC | $5.879.892 | 70.401 | 0,08% | Saham |
| PNC Financial Services Group, Inc. | $5.687.294 | 68.095 | 0,07% | Saham |
| Squarepoint Ops LLC | $5.369.083 | 64.285 | 0,07% | Saham |
| Cinctive Capital Management LP | $5.110.088 | 61.184 | 0,07% | Saham |
| RAYMOND JAMES FINANCIAL INC | $4.965.598 | 59.454 | 0,07% | Saham |
Orang dalam perusahaan 51 orang dalam · 23 pejabat · 21 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 10 Des. 2025 F | 65.900 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 19 Maret 2025 S | 62.688 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 14 Maret 2025 D | 36.257 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 12 Juni 2023 S | 68.690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 2 Maret 2018 A | 62.902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 15 Maret 2016 S | 31.000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 14 Maret 2025 D | 81.374 | 0 | 0 | $0 |
| James P Breslawski | President | 14 Maret 2025 D | 200.227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 6 Maret 2017 A | 9.654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 7 Maret 2013 M | 48.716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 19 Nov. 2025 G | 101.622 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 16 Maret 2026 F | 98.372 | 0 | 2 | $-478.758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 14 Maret 2025 D | 43.191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 6 Sep. 2024 S | 71.833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 26 Mei 2022 S | 95.616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 30 Nov. 2018 S | 68.012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 6 Sep. 2017 S | 17.841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 12 Mei 2017 S | 22.943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 20 Maret 2017 M | 23.088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 13 Maret 2017 S | 14.277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 8 Maret 2017 S | 16.589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 2 Maret 2016 F | 25.144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 17 Maret 2015 S | 12.343 | 0 | 0 | $0 |
| William K Daniel | Direktur | 12 Juni 2026 A | 7.641 | 1 | 0 | $691.900 |
| Bradley T Sheares | Direktur | 6 Maret 2026 A | 47.623 | 0 | 0 | $0 |
| Philip A Laskawy | Direktur | 6 Maret 2026 A | 24.538 | 0 | 1 | $-228.544 |
| Reed Vaughn Tuckson | Direktur | 11 Juni 2025 F | 9.943 | 0 | 0 | $0 |
| Carol Raphael | Direktur | 21 Mei 2025 F | 33.538 | 0 | 0 | $0 |
| Anne H. Margulies | Direktur | 5 Maret 2025 F | 20.576 | 0 | 0 | $0 |
| Scott Philip Serota | Direktur | 4 Maret 2025 A | 8.213 | 0 | 0 | $0 |
| Carole T Faig | Direktur | 4 Maret 2025 A | 5.448 | 0 | 0 | $0 |
| Mohamad Ali | Direktur | 4 Maret 2025 A | 12.498 | 0 | 0 | $0 |
| Robert J. Hombach | Direktur | 4 Maret 2025 A | 2.844 | 0 | 0 | $0 |
| Steven Paladino | Direktur | 4 Maret 2024 A | 138.272 | 0 | 0 | $0 |
| Dianne E Rekow | Direktur | 16 Maret 2022 A | 18.526 | 0 | 0 | $0 |
| Barry J Alperin | Direktur | 16 Maret 2022 A | 52.473 | 0 | 0 | $0 |
| Paul Brons | Direktur | 3 Maret 2021 F | 16.854 | 0 | 0 | $0 |
| Shira Goodman | Direktur | 3 Maret 2021 A | 5.689 | 0 | 0 | $0 |
| Lawrence S Bacow | Direktur | 6 Maret 2018 F | 10.115 | 0 | 0 | $0 |
| Donald J Kabat | Direktur | 6 Maret 2018 F | 10.874 | 0 | 0 | $0 |
| Louis W Sullivan | Direktur | 31 Maret 2016 A | 14.096 | 0 | 0 | $0 |
| Norman S Matthews | Direktur | 31 Maret 2016 A | 12.890 | 0 | 0 | $0 |
| Karyn Mashima | Direktur | 10 Maret 2014 F | 19.269 | 0 | 0 | $0 |
| Irving Shafran | Direktur | 20 Nov. 2003 S | 750.000 | 0 | 0 | $0 |
| HENRY SCHEIN INC | Pemilik 10% | 7 Feb. 2019 J | 0 | 0 | 0 | $0 |
| Stanley M Bergman | — | 26 Mei 2026 G | 253.279 | 0 | 5 | $-7.544.687 |
| Kurt P Kuehn | — | 10 Maret 2026 S | 15.420 | 0 | 1 | $-224.562 |
| Deborah Derby | — | 6 Maret 2026 A | 15.093 | 0 | 0 | $0 |
| Joseph L Herring | — | 6 Maret 2026 A | 30.325 | 0 | 0 | $0 |
| Margaret A Hamburg | — | 20 Mei 2009 M | 0 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 pengajuan | 10 Maret 2026 | 16,40% | Amandemen | — | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 pengajuan | 8 Agu 2025 | 13,00% | Amandemen | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 124 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,69% | 150.301 SH | 8 Agu 2026 | Harian |
| FLV · AMERICAN CENTURY ETF TRUST | 1,67% | 76.819 NS | 31 Mei 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,31% | 154.050 NS | 30 April 2026 | N-PORT |
| GURU · Global X Funds | 1,05% | 8.187 NS | 30 April 2026 | N-PORT |
| TAX · EA Series Trust | 0,98% | 3.244 NS | 29 Mei 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,64% | 123.268 SH | 8 Agu 2026 | Harian |
| SMMV · iShares Trust | 0,60% | 19.668 SH | 8 Agu 2026 | Harian |
| FBCV · FIDELITY COVINGTON TRUST | 0,35% | 7.509 NS | 30 April 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,31% | 13.083 NS | 30 April 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 17.947 NS | 30 April 2026 | N-PORT |
| ANEW · ProShares Trust | 0,28% | 283 NS | 31 Mei 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,28% | 55.872 SH | 8 Agu 2026 | Harian |
| ISCV · iShares Trust | 0,26% | 20.602 SH | 8 Agu 2026 | Harian |
| DEUS · DBX ETF Trust | 0,22% | 7.905 NS | 29 Mei 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,22% | 4.614 NS | 31 Mei 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.354.606 SH | 8 Agu 2026 | Harian |
| DFVE · DoubleLine ETF Trust | 0,21% | 765 NS | 31 Maret 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,20% | 181 NS | 31 Mei 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,20% | 16.567 NS | 30 April 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,18% | 245 NS | 31 Mei 2026 | N-PORT |
| ESML · iShares Trust | 0,18% | 58.273 SH | 8 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,18% | 333.590 NS | 30 April 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 55.767 NS | 30 April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,17% | 1.416.056 SH | 8 Agu 2026 | Harian |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 42.689 NS | 30 April 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,14% | 270.326 NS | 31 Mei 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 4.118 NS | 30 April 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 58.901 SH | 8 Agu 2026 | Harian |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 24.631 NS | 30 April 2026 | N-PORT |
| ISCB · iShares Trust | 0,13% | 4.208 SH | 8 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 48.980 NS | 30 April 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,12% | 21.075 NS | 30 April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,12% | 293.098 SH | 8 Agu 2026 | Harian |
| SMMD · iShares Trust | 0,12% | 49.577 SH | 8 Agu 2026 | Harian |
| RXL · ProShares Trust | 0,11% | 1.043 NS | 31 Mei 2026 | N-PORT |
| IXJ · iShares Trust | 0,11% | 51.636 SH | 8 Agu 2026 | Harian |
| CURE · Direxion Shares ETF Trust | 0,11% | 1.994 NS | 30 April 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.230.411 SH | 8 Agu 2026 | Harian |
| IEDI · iShares U.S. ETF Trust | 0,10% | 316 SH | 8 Agu 2026 | Harian |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 9.299 SH | 8 Agu 2026 | Harian |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7.550 SH | 8 Agu 2026 | Harian |
| IWS · iShares Trust | 0,08% | 148.171 SH | 8 Agu 2026 | Harian |
| DFAT · Dimensional ETF Trust | 0,08% | 146.387 NS | 30 April 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 5.958 SH | 8 Agu 2026 | Harian |
| TILT · FlexShares Trust | 0,08% | 20.790 NS | 30 April 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 82.484 SH | 8 Agu 2026 | Harian |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 7.214 SH | 8 Agu 2026 | Harian |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 6.605 NS | 30 April 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 401.448 SH | 8 Agu 2026 | Harian |
| JSTC · Tidal Trust I | 0,06% | 2.708 NS | 31 Mei 2026 | N-PORT |